MYD88 and inborn error of immunity: This indicates that patients with MyD88 deficiency must be monitored for the development of autoreactive B cells and that improvement in the genetic diagnosis of this primary immunodeficiency worldwide could provide a priceless opportunity to uncover new MyD88-dependent mechanisms that orchestrate the adaptive immune response.